bipolar%20disorder
BIPOLAR DISORDER
Bipolar I disorder is primarily defined by manic or mixed episodes that last for at least 7 days, or very severe manic symptoms needing immediate hospital care. The patient also has depressive episodes which may last for at least 2 weeks.
Bipolar II disorder is usually misdiagnosed. It is characterized by occurence of ≥1 major depressive episodes with at least 1 hypomanic episode.
Cyclothymic disorder or cyclothymia is a mild form of bipolar disorder. Patients have  episodes of hypomania alternating with mild depression that lasts for 2 years.
Rapid-cycling bipolar disorder patients have ≥4 episodes of major depression, mania, hypomania or mixed symptoms within a year.

Patient Education

General Recommendations

Patient and Family Education

  • Treatment plan needs to be discussed with both patient and family members
    • Discuss expected results, dosing strategies, side effects and drug interactions
  • They need to understand that long-term treatment is necessary
    • Education should continue throughout treatment
  • Educate patient and family about prodromal symptoms
    • Teach them to recognize early signs and symptoms of manic and depressive episodes and how to prevent
    • Patient may keep diary of events and moods over time to assist in this process
    • Teach them about destigmatization and non-discrimination

Treatment Compliance

  • Encourage treatment compliance because noncompliance may lead to relapse
    • Must overcome patient’s ambivalence towards treatment
    • Patient may find mania/euphoric episode enjoyable hence fueling reluctance to medication

Manage Functional Impairment

  • Patients may suffer emotional, family, social, occupational, financial or academic problems during an episode
  • Full functional recovery rarely occurs within 12 weeks following the remission of mood symptoms
    • May need assistance in addressing the psychosocial consequences of their actions
    • Patient should be advised to withdraw from work or other responsibilities when needed
    • Major life decisions should not be done while in depressed, manic or hypomanic state

Psychosocial Stressors

  • Enhance coping strategy & problem solving skills in managing psychosocial stressors
  • Disruption in sleep cycles or social rhythm can trigger manic episodes
    • Disruption of sleep is usually the final common pathway trigerring manic episodes
    • Patient and family should be educated on the potential consequences and taught coping strategies
    • Patient may benefit from regular daily activity pattern, including eating, sleeping and physical activities along with emotional and social stimulation
  • Proper assessment, advice and treatment is required in managing patients who abuse substance/alcohol
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
18 Jun 2019
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
6 days ago
The choice between nonvitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) for stroke prevention appears to be complex and largely heterogenous across different, countries, a new study has found.
Yesterday
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Elvira Manzano, Yesterday
Long-term treatment with the interleukin-5 receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.